Lazard Asset Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$660K Buy
9,262
+549
+6% +$37.5K ﹤0.01% 1296
2025
Q4
$516K Hold
8,713
﹤0.01% 1371
2025
Q3
$481K Sell
8,713
-30,333
-78% -$1.58M ﹤0.01% 1360
2025
Q2
$1.68M Buy
39,046
+34,631
+784% +$1.34M ﹤0.01% 1073
2025
Q1
$173K Buy
4,415
+4,304
+3,877% +$190K ﹤0.01% 1660
2024
Q4
$4K Sell
111
-174,167
-100% -$7.25M ﹤0.01% 2147
2024
Q3
$6.8M Buy
174,278
+24,048
+16% +$958K 0.01% 557
2024
Q2
$6.57M Buy
150,230
+16,762
+13% +$810K 0.01% 612
2024
Q1
$6.37M Sell
133,468
-157,815
-54% -$7.09M 0.01% 638
2023
Q4
$13.8M Sell
291,283
-33,914
-10% -$1.41M 0.02% 477
2023
Q3
$15.5M Sell
325,197
-88,174
-21% -$4.81M 0.02% 444
2023
Q2
$24M Sell
413,371
-10,449
-2% -$627K 0.03% 361
2023
Q1
$30.3M Sell
423,820
-32,853
-7% -$2.61M 0.04% 315
2022
Q4
$32.2M Sell
456,673
-74,852
-14% -$5.28M 0.04% 296
2022
Q3
$32.2M Sell
531,525
-64,513
-11% -$4.33M 0.05% 297
2022
Q2
$37.6M Sell
596,038
-16,045
-3% -$1.05M 0.05% 284
2022
Q1
$39.2M Sell
612,083
-28,049
-4% -$1.88M 0.05% 326
2021
Q4
$45.9M Sell
640,132
-49,713
-7% -$3.78M 0.05% 304
2021
Q3
$49.2M Sell
689,845
-17,143
-2% -$1.35M 0.06% 284
2021
Q2
$57.5M Buy
706,988
+2,064
+0.3% +$166K 0.06% 251
2021
Q1
$53.2M Sell
704,924
-57,028
-7% -$4.15M 0.06% 236
2020
Q4
$57.7M Buy
761,952
+41,775
+6% +$2.72M 0.07% 215
2020
Q3
$35.6M Sell
720,177
-20,538
-3% -$1.16M 0.05% 283
2020
Q2
$38.9M Buy
740,715
+96,985
+15% +$4.6M 0.06% 220
2020
Q1
$22.7M Buy
643,730
+177,501
+38% +$10.4M 0.04% 286
2019
Q4
$40.7M Buy
466,229
+19,591
+4% +$1.71M 0.06% 210
2019
Q3
$37.9M Buy
446,638
+50,510
+13% +$4.5M 0.06% 216
2019
Q2
$41.7M Buy
396,128
+100,145
+34% +$10.1M 0.07% 201
2019
Q1
$31.3M Sell
295,983
-66,930
-18% -$6.72M 0.05% 240
2018
Q4
$30.4M Sell
362,913
-140,440
-28% -$12.7M 0.06% 219
2018
Q3
$51.3M Buy
503,353
+10,620
+2% +$1.03M 0.08% 170
2018
Q2
$39.8M Buy
492,733
+44,059
+10% +$3.5M 0.07% 194
2018
Q1
$33.1M Sell
448,674
-64,770
-13% -$4.85M 0.06% 220
2017
Q4
$36.2M Buy
513,444
+6,908
+1% +$498K 0.06% 211
2017
Q3
$31.6M Sell
506,536
-37,001
-7% -$2.19M 0.06% 221
2017
Q2
$31.2M Sell
543,537
-72,605
-12% -$4.27M 0.06% 222
2017
Q1
$37.5M Sell
616,142
-142,858
-19% -$8.08M 0.07% 187
2016
Q4
$41.6M Buy
759,000
+176,731
+30% +$8.48M 0.08% 165
2016
Q3
$26.8M Sell
582,269
-285,027
-33% -$12M 0.05% 213
2016
Q2
$29.5M Buy
+867,296
New +$27.1M 0.06% 192

Other funds holding NGVT

Lazard Asset Management's NGVT Position: Q1 2026 in Review

Lazard Asset Management increased its Ingevity (NGVT) stake by 6.3% in Q1 2026, buying an estimated $37.5K and bringing the position to 9,262 shares worth $660K. The position accounts for ﹤0.01% of the portfolio, ranked #1296.

Lazard Asset Management first reported a position in NGVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $57.7M in Q4 2020. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Lazard Asset Management held 9,262 shares of Ingevity worth $660K as of Q1 2026.
  • Lazard Asset Management bought 549 Ingevity shares in Q1 2026, an estimated $37.5K.
  • Ingevity made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #1296 holding.
  • Lazard Asset Management first reported a position in Ingevity in Q2 2016 and has held it in 40 quarters since.
  • Lazard Asset Management's Ingevity position peaked at $57.7M in Q4 2020.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.